Loading insider details...
Latest Form 4 (Jun 1, 2026): Exercise/Conversion of 8,107 ACAD shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 1, 2026 | ACADIA PHARMACEUTICALS INC (ACAD) | Exercise/Conversion | 8,107 | n/a |
| Jun 2, 2025 | ACADIA PHARMACEUTICALS INC (ACAD) | Exercise/Conversion | 9,387 | n/a |
| Oct 15, 2024 | ACADIA PHARMACEUTICALS INC (ACAD) | Exercise/Conversion | 4,381 | n/a |
| May 31, 2024 | ACADIA PHARMACEUTICALS INC (ACAD) | Exercise/Conversion | 6,652 | n/a |
| Feb 8, 2024 | DBV Technologies S.A. (DBVT) | Purchase | 1,825 | $1.6K |
| Oct 16, 2023 | ACADIA PHARMACEUTICALS INC (ACAD) | Exercise/Conversion | 4,381 | n/a |
| Jun 6, 2023 | ACADIA PHARMACEUTICALS INC (ACAD) | Grant/Award | 11,045 | n/a |
| Oct 14, 2022 | ACADIA PHARMACEUTICALS INC (ACAD) | Grant/Award | 14,077 | n/a |
| Jun 11, 2021 | DBV Technologies S.A. (DBVT) | Purchase | 6,837 | $48.7K |